Building Sustainable Integrative Medicine Programs: Lessons from Health Systems: by Dr. Kim
- John Kim

- Apr 10, 2022
- 12 min read
Updated: 4 days ago

Building Integrative Medicine Programs That Last: Lessons From Two Health Systems — and What the Data Now Tells Us
By Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician
The landscape of healthcare continues to evolve, and the ground beneath integrative medicine has shifted more in the past five years than in the previous twenty. Patients are no longer politely asking whether their health system offers whole-person care — they are voting with their feet and their wallets. As a consultant specializing in integrative and functional medicine implementation, I've witnessed firsthand how health systems can transform their care delivery models, and I've also walked past the graveyard of programs that never made it. Today, I want to share a story that illustrates the critical factors that determine success or failure — and then place that story in the context of what the current evidence and market data actually show.
The Demand Is No Longer Debatable
When I began this work, the standard boardroom objection was some version of: "Is there really enough demand to justify the investment?" That question has been answered decisively — by patients themselves and by two decades of national survey data.
An NIH-funded analysis published in JAMA, drawing on the National Health Interview Survey, found that the percentage of U.S. adults using at least one of seven complementary health approaches (yoga, meditation, massage therapy, chiropractic care, acupuncture, naturopathy, and guided imagery/progressive muscle relaxation) nearly doubled over twenty years — from 19.2% in 2002 to 36.7% in 2022. Meditation became the most-used approach, climbing from 7.5% to 17.3%, and yoga use more than tripled, from 5% to 15.8%. Just as important for health-system strategists: among users of these approaches, the share using them specifically for pain management rose from 42.3% to 49.2% — a shift the study's authors attribute in part to the movement away from opioids, better-quality supporting research, and the incorporation of complementary approaches into clinical practice guidelines.
The economics tell the same story at a larger scale. The Global Wellness Institute's most recent Global Wellness Economy Monitor puts the worldwide wellness economy at a record $6.8 trillion in 2024, with a projected 7.6% annual growth rate carrying it toward nearly $9.8 trillion by 2029 — a growth rate well above projected global GDP growth. Notably, traditional and complementary medicine is projected to be among the fastest-growing wellness segments over the next five years. Market research firms tracking complementary and alternative medicine as a distinct category consistently forecast double-digit compound annual growth through the early 2030s, driven by chronic disease prevalence, consumer preference for holistic care, and the steady integration of these therapies into mainstream delivery systems.
For a health system, this data reframes the question entirely. Integrative medicine is no longer a boutique amenity competing for discretionary budget. It is a documented consumer movement that your patients are already participating in — with or without your guidance, and with or without your revenue capture.
My Journey into Healthcare Transformation
My perspective on integrative medicine implementation was shaped during my time as a residential fellow in Dr. Andrew Weil's renowned Integrative Medicine Fellowship at the University of Arizona. This experience opened my eyes to the vast potential of combining conventional medicine with evidence-based complementary approaches. During the fellowship, I made it my mission to visit, study, and research existing business models across the United States.
What I discovered was both inspiring and sobering. While many institutions had attempted to launch integrative medicine programs, the sustainability rates were alarmingly low. The graveyard of failed programs was littered with good intentions but poor strategic planning. This research became the foundation for my consulting approach, emphasizing practical implementation strategies over theoretical ideals.
It is worth pausing on how much institutional legitimacy the field has accumulated since those early days. The Academic Consortium for Integrative Medicine & Health — the organizational home for academic institutions committed to this work — has grown to more than 86 member institutions across the United States, Australia, Brazil, Canada, Japan, and South Korea, all accredited academic health centers, hospitals, health systems, osteopathic medical centers, or nursing schools with active integrative programs in at least two of three areas: education, research, and clinical care. When I was doing my initial business-model research, membership in that community was a fraction of its current size. The infrastructure of the field — training pathways, board certification, peer-reviewed evidence, professional societies — has matured dramatically. What has not changed is the strategic discipline required to make an individual program survive.
Institution A: Leveraging Community Strengths
Shortly after completing my fellowship, I had the opportunity to engage with what I'll call Institution A — a community-based hospital system facing a formidable challenge. They were competing directly with a world-renowned academic medical center that had already established its own integrative medicine program. On paper, this seemed like David versus Goliath.
However, I saw something different. While the academic center had prestige and research capabilities, Institution A possessed unique advantages that were being underutilized. My assessment revealed two critical strategic opportunities.
The Multiple Locations Advantage
The first recommendation centered on Institution A's greatest asset: their multiple locations throughout the community. Instead of trying to compete head-to-head with a single flagship program, I advised them to create a distributed network of integrative services. This approach would accomplish several objectives:
Increased accessibility: Patients wouldn't need to travel to a single academic center to receive integrative care.
Community integration: Services could be tailored to specific neighborhood demographics and needs.
Referral capture: Over time, the network would reduce the referral base flowing to the competing academic program.
This distributed-network strategy has since been validated at the largest scale in American healthcare. In 2018, the Veterans Health Administration — the largest integrated health system in the country — launched its Whole Health System at one flagship facility in each of its 18 regional networks, deliberately building a distributed model rather than a single center of excellence. The results informed national policy: a partnered evaluation found that opioid use decreased by 23% to 38% among Whole Health users (depending on level of engagement), compared with an 11% decrease among veterans receiving conventional care. Those findings were cited directly in the VA's executive decision to expand Whole Health system-wide. More recent VA data shows 40% of veterans with chronic musculoskeletal pain experiencing meaningful improvements in pain interference with complementary and integrative therapies, along with better diabetes and blood pressure control and tobacco quit rates 11% to 23% higher among participants using meditation, wellness coaching, or acupuncture. When the nation's largest health system stakes a modernization initiative on distributed whole-person care and documents outcomes at that scale, community health systems should take notice.
Function-Based Specialization
My second recommendation involved developing function-based integrative programs rather than attempting to be everything to everyone. I suggested focusing on areas where they could demonstrate clear value and outcomes:
Integrative Oncology: Combining conventional cancer treatments with evidence-based complementary therapies to manage side effects and improve quality of life. This was a forward-looking bet at the time; it is now mainstream. The Society for Integrative Oncology and the American Society of Clinical Oncology have jointly published evidence-based clinical practice guidelines covering integrative approaches to cancer-related pain (2022), anxiety and depression (2023), and fatigue (2024) — formally recommending interventions such as mindfulness-based programs, yoga, acupuncture, and music therapy within standard oncology care. A survey of NCCN member institutions published in 2026 found that all twenty-nine responding centers offer integrative oncology services, and integrative oncology has become an expected component of care at most National Cancer Institute–designated comprehensive cancer centers. A cancer center without an integrative program is increasingly the outlier, not the norm.
Integrative Pain Management: Offering alternatives to opioid-dependent treatment protocols through acupuncture, mindfulness-based stress reduction, and targeted nutritional interventions. Here, too, the policy environment has caught up with the clinical logic. The CDC's 2022 Clinical Practice Guideline for Prescribing Opioids for Pain states plainly that nonopioid therapies are preferred for subacute and chronic pain, and directs clinicians to maximize nonpharmacologic therapies — noting that noninvasive interventions such as exercise and psychological therapies produce improvements in pain and function that are sustained after treatment and are not associated with serious harms. An integrative pain program is no longer swimming against guideline currents; it is the guideline-concordant answer to one of medicine's most pressing problems.
Beyond clinical outcomes, function-based programs can create measurable financial value — a point I emphasize with every institution I advise. When integrative services are woven into pain management pathways, the reduction in opioid reliance documented in settings like the VA carries real cost implications, and in my experience institutions also see benefits in patient retention and reduced downstream utilization. Integrative oncology programs, similarly, can differentiate a cancer center in a competitive market and support referral volume that extends well beyond the integrative clinic itself. These are the metrics that resonate in the boardroom, and programs that track them are far better positioned to defend their budgets.
These specialized programs would allow Institution A to build deep expertise and measurable outcomes in specific areas rather than spreading resources too thin across multiple disciplines.
The Results Speak Volumes
Institution A implemented my first recommendation with remarkable success. They systematically rolled out integrative medicine services across their network of community locations. Today, Institution A and integrative medicine have become synonymous with comprehensive healthcare in their region. Patients no longer view them as the "smaller" alternative to the academic center — they're seen as the accessible, community-focused leader in whole-person care.
This transformation didn't happen overnight. It required consistent investment, staff training, and most importantly, a commitment to measuring and communicating outcomes. But the results have been sustainable, which is the true measure of success in this field.
Institution B: The Entrepreneurial Turnaround
While I didn't directly engage with Institution B, their story serves as a powerful example of resilience and strategic adaptation. This institution initially struggled with their integrative medicine program, cycling through frequent leadership changes. The key insight from their board was telling: "We need entrepreneurial leadership."
This recognition was crucial. Many healthcare institutions approach integrative medicine with traditional healthcare administration mindsets. However, these programs often require entrepreneurial thinking — the ability to innovate, take calculated risks, and adapt quickly to market feedback.
Learning from Afar
What impressed me most about Institution B was their ability to learn and adapt without direct consultation. From what I could observe, after cycling through leadership they eventually narrowed their focus — moving away from a broad-spectrum program toward clinical depth in the specific areas where integrative approaches could demonstrate clear, trackable value. It appeared to be a version of my second recommendation: concentrating resources rather than scattering them, and building a program that could defend its outcomes and prove its relevance to referring physicians.
Their journey illustrates an important principle: sometimes the willingness to acknowledge what isn't working and make dramatic changes is more valuable than having the perfect strategy from the start. Institution B's turnaround also suggests that the entrepreneurial leader a board hires must be willing to sunset programs that aren't performing in order to invest in those that are — a discipline that distinguishes sustainable integrative programs from expensive experiments.
The Bigger Picture: Why Programs Still Fail
The success stories of both institutions are remarkable not just for their individual achievements, but for what they represent in a challenging landscape. Even with demand at historic highs and guideline support strengthening every year, integrative programs continue to close. Having examined this failure pattern for two decades, I find the causes remarkably consistent:
Lack of clear business strategy. Programs launched on enthusiasm and philanthropy without a plan for what happens when the seed funding runs out.
Insufficient integration with existing clinical workflows. If referring physicians cannot order integrative services as easily as they order physical therapy, the program remains an island — and islands get defunded. Implementation research within the VA Whole Health rollout reached the same conclusion: system-wide success depends on implementation structure and processes that support integration at the local level, not just on the merits of the services themselves.
Failure to measure and communicate outcomes. The VA's expansion decision is the definitive case study here: leadership initially declined to endorse system-wide expansion until evaluators produced patient-outcome data. The data — particularly the opioid reduction findings — became the explicit foundation for the executive decision to expand. Programs that cannot produce their own version of that evidence will not survive their first serious budget review.
Underestimating the cultural change required. Whole-person care asks clinicians to practice differently, not just to add a referral option.
Inadequate leadership commitment. Sustainable programs take years; leadership turnover without succession planning has killed more integrative programs than any budget shortfall.
A reimbursement model built on hope. Coverage for services like acupuncture has genuinely improved and contributed to expanded access, but successful programs are designed around a realistic mix of insured services, cash-pay offerings, membership models, and downstream referral value — not on the assumption that payers will eventually cover everything.
Lessons for Healthcare Leaders
Based on these experiences and my broader consulting work, several key principles emerge for healthcare systems considering integrative medicine programs:
Start with your strengths. Don't try to copy what works elsewhere. Assess your unique advantages — whether that's geographic distribution, existing specialties, or community relationships.
Think function, not fashion. Focus on specific clinical areas where integrative approaches can demonstrate measurable value — oncology support and pain management now carry formal guideline backing — rather than trying to be comprehensive from day one.
Embrace entrepreneurial leadership. Traditional healthcare administration skills are necessary but not sufficient. You need leaders who can innovate and adapt quickly.
Plan for the long term. Sustainable programs require years to build. Resist the temptation to expect immediate dramatic returns on investment.
Measure everything. Without data demonstrating clinical and financial outcomes, programs remain vulnerable to budget cuts during challenging times. Build your evaluation plan before you see your first patient, and choose metrics that speak to executives: opioid reduction, patient-reported outcomes, retention, downstream referrals, and market differentiation.
Anchor to the guidelines. The SIO-ASCO oncology guidelines and the CDC pain guideline give integrative programs something they never had before: the ability to describe their services as guideline-concordant care rather than an optional add-on. Use that language with medical staff, payers, and boards.
The Path Forward: Sustainable Integrative Medicine
The healthcare landscape continues to shift toward value-based care and patient-centered approaches. Integrative medicine is no longer a "nice to have" but increasingly a competitive necessity. More than a third of American adults are already using these approaches. National guidelines now formally recommend them for pain, cancer symptom management, anxiety, depression, and fatigue. The largest health system in the country has made whole-person care a pillar of its modernization strategy and documented the outcomes. Health systems that don't adapt risk losing market share — and clinical relevance — to those that do.
This is especially true in a fiscal environment that demands justification for every new line item. Health-system budgets in 2026 are being written with caution, and even federally backed programs face scrutiny around staffing and operational efficiency. That reality makes the strategic discipline outlined above not optional but essential: programs that can demonstrate financial sustainability and clinical value will survive; programs that rely on institutional enthusiasm alone will not.
For healthcare administrators considering this journey, the stories of these two institutions offer both inspiration and practical guidance. Institution A shows how leveraging existing strengths can create competitive advantage. Institution B demonstrates that resilience and adaptability can overcome initial setbacks. And the national data — from NHIS utilization trends to VA outcomes to joint specialty-society guidelines — shows that the strategic bets both institutions made are now the documented direction of American healthcare.
The question isn't whether integrative medicine will become mainstream in healthcare — it already has. The question is whether your institution will be a leader or a follower in this transformation.
Dr. Yoon Hang Kim has established and operated integrative and functional medicine programs in multiple health systems — including serving as Medical Director of Integrative Oncology at Miami Cancer Institute and Director of the Integrative Medicine Program at the University of Kansas Medical Center — and is available to provide consulting services for organizations seeking to implement or strengthen their own programs.
About Dr. Kim
Dr. Yoon Hang "John" Kim is board-certified in Preventive Medicine and is an Integrative & Functional Medicine Physician with over 20 years of clinical experience. He completed his Integrative Medicine Fellowship under Dr. Andrew Weil at the University of Arizona and holds additional certifications in medical acupuncture (UCLA) and integrative/holistic medicine. He is an IFM Scholar and has served in leadership roles across multiple health systems, including as Medical Director of Integrative Oncology at Miami Cancer Institute and Director of the Integrative Medicine Program at the University of Kansas Medical Center.
Dr. Kim specializes in low dose naltrexone (LDN), autoimmune conditions, chronic pain, integrative oncology, fibromyalgia, chronic fatigue syndrome, mast cell activation syndrome (MCAS), and mold toxicity. He is the author of three books — including LDN Primer and LDN for Clinicians, Researchers, and Empowered Patients — and has published more than 20 peer-reviewed articles.
Professional: www.yoonhangkim.com
Clinical: www.directintegrativecare.com
Sources
Nahin RL, Rhee A, Stussman B. Use of Complementary Health Approaches Overall and for Pain Management by US Adults in 2002, 2012, and 2022. JAMA. 2024. Summary via NIH/NCCIH: https://www.nih.gov/news-events/news-releases/nih-analysis-reveals-significant-rise-use-complementary-health-approaches-especially-pain-management
Global Wellness Institute. Global Wellness Economy Monitor 2025 (wellness economy at $6.8 trillion in 2024; projected ~$9.8 trillion by 2029). https://globalwellnessinstitute.org/industry-research/2025-global-wellness-economy-monitor/
Academic Consortium for Integrative Medicine & Health. Member institutions and mission. https://imconsortium.org/
U.S. Department of Veterans Affairs. Expanding the VA Whole Health System (18 flagship sites, 2018). https://www.va.gov/WHOLEHEALTH/features/Expanding_the_VA_Whole_Health_System.asp
Bokhour BG, et al. From patient outcomes to system change: Evaluating the impact of VHA’s implementation of the Whole Health System of Care. Health Serv Res. 2022 (opioid use decreased 23%–38% among Whole Health users vs. 11% with conventional care). https://pmc.ncbi.nlm.nih.gov/articles/PMC9108226/
VA News. Whole Health services improve outcomes for Veterans. 2026 (pain interference, diabetes and blood pressure control, tobacco cessation findings). https://news.va.gov/146810/whole-health-services-improve-outcomes-veterans/
Mao JJ, et al. Integrative Medicine for Pain Management in Oncology: SIO–ASCO Guideline. J Clin Oncol. 2022; Carlson LE, et al. Integrative Oncology Care of Symptoms of Anxiety and Depression in Adult Patients with Cancer: SIO–ASCO Guideline. J Clin Oncol. 2023; Bower JE, et al. Management of Fatigue in Adult Survivors of Cancer: ASCO–SIO Guideline Update. J Clin Oncol. 2024. Guideline index: https://integrativeonc.org/practice-guidelines/
Synthesis and Educational Overview of the ASCO–Society for Integrative Oncology Guidelines. ASCO Educational Book. 2025 (pain, anxiety/depression, and fatigue guidelines; NCI-designated center adoption). https://ascopubs.org/doi/10.1200/EDBK-25-471830
National Comprehensive Cancer Network Best Practices Committee survey of member institutions (100% of responding centers offering integrative oncology services). JADPRO. 2026. https://jadpro.com/online-first/2026/integrative-oncology-models-of-care-practice-patterns-from-nccn-member-institutions/
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep. 2022;71(RR-3):1–95. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
Identifying Barriers and Facilitators to Veterans Affairs Whole Health Integration Using the Updated Consolidated Framework for Implementation Research. J Gen Intern Med. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11065588/
Comments